The Faces of Luminex: Robin Murphy, Systems Integration

The Luminex R&D teams for hardware, software, reagents, and assays operate mostly independently—which means we need great scientists to pull each of these elements together and ensure a seamless user experience. For this, we rely on Robin Murphy, Scientist II, who has been part of our family since 2006. He earned a bachelor’s in chemistry […]

Read More…

METHODS Special Issue: Multiplexing Protocol for Evaluating Biological Interactions with Nanoparticles

A new multiplexing protocol offers guidelines for measuring immunomodulatory effects of nanoparticles used in clinical applications Nanoparticles have the potential to deliver more targeted therapies to the exact location in the body where they’re most needed. To do this, it is essential to understand how these foreign particles interact with a patient’s body. A recent […]

Read More…

The Faces of Luminex: Martin Kochanczyk, Advanced Technologies Group

Our advanced technologies team is tasked with a mission that’s both challenging and fun: keeping Luminex at the cutting edge by figuring out what will be needed in the coming years and developing technology solutions to meet those needs. Physicist Martin Kochanczyk, Senior Manager of Technology Development, is one of the team members responsible for […]

Read More…

METHODS Special Issue: Multiplexing for Personalized Oncology

Assays quantify RNA expression even in challenging samples Multiplex molecular assays have several important roles in the realm of personalized cancer medicine. A team of researchers at the University of Malta recently published a paper, titled “Bead-based RNA multiplex panels for biomarker detection in oncology samples,” in the Methods journal that offers an overview of […]

Read More…

The Faces of Luminex: Brian Walsh, Technical Applications

We work hard to deliver robust systems and consumables to our customers, but even with the best quality control, occasional hiccups are unavoidable. That’s why we count on Brian Walsh, Technical Applications Specialist, to work closely with our customers and address any issues they may encounter. He joined Luminex in 2018, and holds a PhD […]

Read More…

Webinar: Improving Rheumatoid Arthritis Diagnostics with Multiplex Assays

How a European team avoided performing 16,000 ELISA tests New efforts to improve the diagnosis of rheumatoid arthritis, as well as to guide treatment selection, are making strong progress thanks to xMAP® Technology from Luminex, according to a recent presentation from Erik Lönnblom of the Karolinska Institute. Multiplex immunoassays have allowed his team and collaborators […]

Read More…

METHODS Special Issue: Multiplexing to Quantify Cytokines and Chemokines in Mouse Brain Study

Assay requires minimal sample volume for 33-analyte interrogation Scientists from the National Institute of Neurological Disorders and Stroke and Bio-Rad Laboratories published a helpful protocol for a method to analyze more than 30 cytokines and chemokines in mouse brain tissue. The technique can be adapted to other sample types as well. The paper, titled “Method […]

Read More…

The Faces of Luminex: Yetzielisse Urgelles, Graphic Design

Whether it’s through our website, social media channels, or a conference booth, if you’ve seen Luminex content lately, then you’re already familiar with our talented creative services team. Today, we’re shining the spotlight on Yetzielisse Urgelles, a gifted graphic designer who joined our team in early 2018 after completing her BFA in graphic and web […]

Read More…

METHODS Special Issue: Clinical and Analytical Performance Data for NxTAG RPP

Highly scalable, multiplex molecular assay is comparable to xTAG RVP performance If you’ve ever used an assay based on xTAG® Technology, you may wonder how the newer NxTAG® Chemistry stacks up. A new publication in Methods uses clinical and analytical data from respiratory pathogen panels to demonstrate how both performance and workflow have improved with […]

Read More…

METHODS Special Issue: New Multiplex Assay for Vaccine Immunogenicity Testing

Recently developed test lowers cost and reduces sample volumes needed for evaluating combination vaccines Scientists at the Serum Institute of India have developed a new multiplex immunoassay to perform the mouse immunogenicity testing recommended in many countries for quality control in the production of combination vaccines. They chose xMAP® Technology to design the serological assay, […]

Read More…